Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Omisirge Market Report 2025

Omisirge Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Leukemia, Lymphoma, Myeloma, Other Hematologic Malignancies), By Distribution Channel (Direct Sales, Distributors), By End User (Hospitals And Clinics, Ambulatory Surgical Centers)

Omisirge Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Omisirge Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Omisirge Market Definition

Omisirge is an advanced cell therapy used in allogeneic hematopoietic stem cell transplantation (HSCT) for patients with blood cancers or disorders. It is derived from umbilical cord blood and designed to expedite neutrophil recovery, reducing the risk of infection and complications after transplantation. Omisirge contains expanded hematopoietic progenitor cells (CD34+ cells) cultured to enhance their number and functionality, enabling faster engraftment compared to standard cord blood transplantation.

The main types of indications for omisirge include Leukemia, Lymphoma, myeloma, and others. Leukemia is a type of cancer that affects the blood and bone marrow, leading to the production of abnormal white blood cells. It is distributed through both direct sales and distributors and is used by hospitals and clinics, and ambulatory surgical centers.

Omisirge Market Segmentation

The omisirge market covered in this report is segmented –

1) By Clinical Indication: Leukemia; Lymphoma; Myeloma; Other Hematologic Malignancies

2) By Distribution Channel: Direct Sales; Distributors

3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers

Omisirge Market Size and growth rate 2025 to 2029: Graph

Omisirge Market Size 2025 And Growth Rate

The omisirge market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the prevalence of chronic disorders, the rise in clinical trials, the increasing geriatric population, rising healthcare infrastructure, and increasing research and development activities.

Omisirge Market Growth Forecast

The omisirge market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing healthcare expenditure, rising government initiatives, rising disposable income, increasing personalized medicines, and growing prevalence of cancer. Major trends in the forecast period include a focus on product launch, strategic collaboration, technological advancement, drug approval by authority, and investment in research and development.

Book your 30 minutes free consultation with our research experts

Contact Us

Omisirge Market Driver: Rising Cancer Incidence Fuels Growth Of The Market

The growing prevalence of cancer is expected to drive the omisirge market. Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells, which can invade nearby tissues and organs and may metastasize to distant parts of the body, potentially leading to life-threatening complications if untreated. The rise in cancer can be attributed to a combination of factors, including increasing exposure to carcinogens such as tobacco smoke, UV radiation, and certain chemicals, along with a growing elderly population, changes in diet and lifestyle, and certain genetic mutations. Omisirge is a cutting-edge treatment that helps cancer patients by targeting and modulating the immune system to enhance the body's natural ability to fight cancer cells, thereby offering a promising therapeutic approach for certain types of cancers, particularly those resistant to traditional therapies. For instance, in January 2023, according to the American Cancer Society, a US-based non-profit cancer advocacy organization, the number of cancer cases increased to 1,958,310 in 2023, reflecting a growth of 3.16% from 1,898,160 in 2021. Therefore, the growing prevalence of cancer is driving the growth of the omisirge market.

Omisirge Market Driver: Rising Demand For Personalized Treatments Driving Growth In The Market

The increasing demand for personalized treatments is expected to propel the growth of the omisirge market going forward. Personalized treatments are medical interventions tailored to an individual's specific genetic, environmental, and lifestyle factors to optimize effectiveness and minimize side effects. The demand for personalized treatments is rising due to advancements in genetic research, increased awareness of individualized healthcare, and the growing recognition that tailored therapies offer improved efficacy and fewer side effects compared to traditional one-size-fits-all approaches. Omisirge enhances personalized treatments by leveraging its ability to adapt to individual patient needs, targeting specific immune responses, and optimizing therapeutic outcomes based on the unique characteristics of each patient's cancer profile. For instance, in February 2023, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, proponents of personalized medicine indicate that it represented 34% of new drug approvals by the US Food and Drug Administration in 2022, and it has made up at least 25% of approvals in each of the prior eight years. Therefore, the increasing demand for personalized treatments is expected to drive the growth of the omisirge market.

Global Omisirge Market Major Players

Major companies operating in the omisirge market are Gamida Cell Ltd.

Global Omisirge Market Trend: Regulatory Approvals Driving Innovation In The Market

The key trend in the omisirge market is obtaining drug approval by authorities to gain a competitive edge in the industry. Drug approval is the process by which regulatory authorities evaluate and authorize a new drug for sale and use, ensuring its safety, efficacy, and quality based on clinical trial data. For instance, in April 2023, Gamida Cell Ltd., a US-based biotechnology company, has gained approval from the U.S. Food and Drug Administration for Omisirge for adult and pediatric patients aged 12 and older with hematologic Patients with malignancies who undergo umbilical cord blood transplantation after myeloablative conditioning. This approval marks a significant advancement in cell therapy for blood cancer patients, as omisirge is designed to expedite neutrophil recovery and reduce infection risk. Administered as a single intravenous dose, omisirge consists of human allogeneic stem cells cultured with nicotinamide (a form of vitamin B3). Each patient's dose is created using healthy stem cells from a carefully selected, unrelated donor, rather than the patient's own cells.

Regional Analysis For The Global Omisirge Market

North America was the largest region in the omisirge market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omisirge market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the omisirge market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Omisirge Market?

The omisirge market consists of sales of cell therapy products, gene therapy products, cord blood-derived products, and tissue engineering products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Omisirge Industry?

The omisirge market research report is one of a series of new reports from The Business Research Company that provides omisirge market statistics, including omisirge industry global market size, regional shares, competitors with an omisirge market share, detailed omisirge market segments, market trends and opportunities, and any further data you may need to thrive in the omisirge industry. This omisirge market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Omisirge Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The omisirge market covered in this report is segmented –
1) By Clinical Indication: Leukemia; Lymphoma; Myeloma; Other Hematologic Malignancies
2) By Distribution Channel: Direct Sales; Distributors
3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Gamida Cell Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Omisirge Market Characteristics

    3. Omisirge Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Omisirge Market Trends And Strategies

    5. Omisirge Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Omisirge Growth Analysis And Strategic Analysis Framework

    6.1. Global Omisirge PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Omisirge Market Growth Rate Analysis

    6.4. Global Omisirge Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Omisirge Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Omisirge Total Addressable Market (TAM)

    7. Global Omisirge Pricing Analysis & Forecasts

    8. Omisirge Market Segmentation

    8.1. Global Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Leukemia

    Lymphoma

    Myeloma

    Other Hematologic Malignancies

    8.2. Global Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Direct Sales

    Distributors

    8.3. Global Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals And Clinics

    Ambulatory Surgical Centers

    9. Global Omisirge Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Omisirge Market Regional And Country Analysis

    10.1. Global Omisirge Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Omisirge Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Omisirge Market

    11.1. Asia-Pacific Omisirge Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Omisirge Market

    12.1. China Omisirge Market Overview

    12.2. China Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Omisirge Market

    13.1. India Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Omisirge Market

    14.1. Japan Omisirge Market Overview

    14.2. Japan Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Omisirge Market

    15.1. Australia Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Omisirge Market

    16.1. South Korea Omisirge Market Overview

    16.2. South Korea Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Omisirge Market

    17.1. Western Europe Omisirge Market Overview

    17.2. Western Europe Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Omisirge Market

    18.1. UK Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Omisirge Market

    19.1. Germany Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Omisirge Market

    20.1. France Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Omisirge Market

    21.1. Eastern Europe Omisirge Market Overview

    21.2. Eastern Europe Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Omisirge Market

    22.1. North America Omisirge Market Overview

    22.2. North America Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Omisirge Market

    23.1. USA Omisirge Market Overview

    23.2. USA Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Omisirge Market

    24.1. Canada Omisirge Market Overview

    24.2. Canada Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Omisirge Market

    25.1. South America Omisirge Market Overview

    25.2. South America Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Omisirge Market

    26.1. Middle East Omisirge Market Overview

    26.2. Middle East Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Omisirge Market

    27.1. Africa Omisirge Market Overview

    27.2. Africa Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Omisirge Market Competitive Landscape And Company Profiles

    28.1. Omisirge Market Competitive Landscape

    28.2. Omisirge Market Company Profiles

    28.2.1. Gamida Cell Ltd. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Omisirge Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Omisirge Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Omisirge Market

    32. Recent Developments In The Omisirge Market

    33. Omisirge Market High Potential Countries, Segments and Strategies

    33.1 Omisirge Market In 2029 - Countries Offering Most New Opportunities

    33.2 Omisirge Market In 2029 - Segments Offering Most New Opportunities

    33.3 Omisirge Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Omisirge Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Omisirge Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Gamida Cell Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Omisirge Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Omisirge Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Omisirge Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Gamida Cell Ltd. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the stem cell therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the regenerative medicine for cartilage market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

Read More

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autologous Cell Therapy Global Market Report 2025 – By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications), By End User (Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Stem Cell Therapy Global Market Report 2025 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others), By End-Users (Hospitals And Clinics, Research Centers, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End User (Life Science Companies, Research Institutes And Cell Banks) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Human Raw Materials Global Market Report 2025 – By Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials), By Type Of Cell Therapy (Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy), By End-Use (Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Allogeneic Cell Therapy Global Market Report 2025 – By Type (Stem Cell Therapies, Non-Stem Cell Therapies), By Therapeutic Area (Hematological Disorders, Dermatological Disorders, Other Therapeutic Area), By End User (Hospitals, Specialty Clinics, Research Organizations) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Personalized Cell Therapy Global Market Report 2025 – By Cell Type (Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type), By Technique (Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation), By Application (Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications), By End-User (Hospital, Homecare, Specialty Clinics, Other End-User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Omisirge market?

Omisirge is an advanced cell therapy used in allogeneic hematopoietic stem cell transplantation (HSCT) for patients with blood cancers or disorders. It is derived from umbilical cord blood and designed to expedite neutrophil recovery, reducing the risk of infection and complications after transplantation. Omisirge contains expanded hematopoietic progenitor cells (CD34+ cells) cultured to enhance their number and functionality, enabling faster engraftment compared to standard cord blood transplantation. For further insights on the Omisirge market, request a sample here

How will the Omisirge market drivers and restraints affect the market dynamics? What forces will shape the Omisirge industry going forward?

The Omisirge market major growth driver - Rising Cancer Incidence Fuels Growth Of The Market. For further insights on the Omisirge market, request a sample here

What is the forecast market size or the forecast market value of the Omisirge market?

The Omisirge market size has grown strongly in recent years. The omisirge market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the prevalence of chronic disorders, the rise in clinical trials, the increasing geriatric population, rising healthcare infrastructure, and increasing research and development activities. The omisirge market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing healthcare expenditure, rising government initiatives, rising disposable income, increasing personalized medicines, and growing prevalence of cancer. Major trends in the forecast period include a focus on product launch, strategic collaboration, technological advancement, drug approval by authority, and investment in research and development. For further insights on the Omisirge market, request a sample here

How is the Omisirge market segmented?

The omisirge market covered in this report is segmented –
1) By Clinical Indication: Leukemia; Lymphoma; Myeloma; Other Hematologic Malignancies
2) By Distribution Channel: Direct Sales; Distributors
3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers For further insights on the Omisirge market, request a sample here

Which region has the largest share of the Omisirge market? What are the other regions covered in the report?

North America was the largest region in the omisirge market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omisirge market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Omisirge market, request a sample here.

Who are the major players in the Omisirge market?

Major companies operating in the omisirge market are Gamida Cell Ltd. . For further insights on the Omisirge market, request a sample here.

What are the key trends in the Omisirge market?

Major trends in the Omisirge market include Regulatory Approvals Driving Innovation In The Market. For further insights on the Omisirge market, request a sample here.

What are the major opportunities in the Omisirge market? What are the strategies for the Omisirge market?

For detailed insights on the major opportunities and strategies in the Omisirge market, request a sample here.

How does the Omisirge market relate to the overall economy and other similar markets?

For detailed insights on Omisirge's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Omisirge industry?

For detailed insights on the mergers and acquisitions in the Omisirge industry, request a sample here.

What are the key dynamics influencing the Omisirge market growth? SWOT analysis of the Omisirge market.

For detailed insights on the key dynamics influencing the Omisirge market growth and SWOT analysis of the Omisirge industry, request a sample here.